Actinium Pharmaceuticals, Inc. 4
4 · Actinium Pharmaceuticals, Inc. · Filed Dec 24, 2013
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Award
Options to purchase common stock
2013-12-16$6.70/sh+675,000$4,522,500→ 675,000 totalExercise: $6.70Exp: 2023-12-16→ Common stock (675,000 underlying)
Footnotes (1)
- [F1]Options granted on December 16, 2013 to purchase an aggregate of 675,000 shares of common stock. A total of 28% of the options will vest one year from the grant date, and 2% per month thereafter. As of the date of this report, no options have vested.